Head-to-head · WeighScore
Coivas vs NovoCare Pharmacy
The verdict
Coivas takes it — 66.2/100 to 55.2/100.
Coivas grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Coivas is an all-inclusive GLP-1 telehealth service operated by WellVi LLC (d/b/a Coivas) with prescriptions through Arora Health & Aesthetics, LLC.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Coivas | NovoCare Pharmacy |
|---|---|---|
| WeighScore | 66.2/100 | 55.2/100 |
| Grade | C | C |
| Scorecard rank | #194 | #442 |
| Semaglutide | $149/mo (quarterly plan, compounded) | $349/mo (2.4 mg dose, brand-name) |
| Tirzepatide | $229/mo (quarterly plan, compounded) | Not disclosed |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #194 · C
Strengths
- All-inclusive pricing: one price covers doctor consult, prescription, shipping and support
- Compounded semaglutide from $149/mo and tirzepatide from $229/mo on the quarterly plan
- Names its clinical provider (Arora Health & Aesthetics, LLC) and cites USP 797 / NABP-accredited pharmacies
- Available in all 50 states; 24/7 support; HSA/FSA eligible; money-back guarantee
- Most patients approved in under 2 hours; refund if no provider visit or prescription occurs
Where it loses points
- Dispensing pharmacies described only by category (503A/503B, NABP-accredited) - not named individually
- Lower quarterly headline price requires a 3-month commitment; monthly plan costs more ($179/$289)
- Money-back guarantee has strict adherence/verification conditions and no partial/prorated refunds
- No brand-name Wegovy/Zepbound/Mounjaro/Ozempic - compounded injectable only; binding NY arbitration
Graded #442 · C
Strengths
- First-party Novo Nordisk pharmacy — the most authoritative branded Wegovy channel
- $199/mo intro pricing on Wegovy 0.25/0.5 mg starter doses (through 6/30/2026), the lowest brand self-pay price
- $349/mo standard self-pay is well below the ~$1,300/mo retail list price
- Ships to all 50 states with no telehealth-platform middleman fees
- Cold-chain logistics handled directly by Novo Nordisk
Where it loses points
- Wegovy only — no Ozempic, no tirzepatide, no compounded GLP-1
- Requires an existing Wegovy prescription — no prescribing clinicians or telehealth intake
- No clinical support included — your own prescriber handles titration and side effects
- Manufacturer-set pricing can change at any time
- $199 pen intro covers only the first 2 fills for new patients (through 6/30/2026); maintenance doses are $349/mo ($399 HD)
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.